Literature DB >> 26051683

Investigation of CTLA-4-318C/T gene polymorphism in cases with type 1 diabetes of Azerbaijan, Northwest Iran.

Shohreh Almasi1, Mohammad Reza Aliparasti2, Akbar Aliasgarzadeh3, Bahareh Abd-Nikfarjam4, Heikki Hyöty5, Mikael Knip6, Hadi Feizi7, Amirbabak Sioofy-Khojine8, Badrossadat Rahnama9.   

Abstract

This study analyzed the association of CTLA-4-318C/T gene polymorphism with susceptibility, clinical course and laboratory findings of Type 1 diabetes (T1D). One hundred and fifty-three T1D patients and 189 healthy controls entered this study. CTLA-4-318C/T genotyping was performed by tetra-primer amplification refractory mutation system-polymerase chain reaction (T-ARMS-PCR) analysis. The allelic and genotypic frequencies of -318C/T gene polymorphism were similar in patients and controls. However, younger age, earlier age at onset, higher HbA1c levels, higher frequency of Glutamic acid decarboxylase antibodies (GADA) and Insulinoma Associated-2 Autoantibodies (IA-2A) were observed in T1D patient carriers of CT genotype. The current study demonstrates that although CTLA-4-318C/T polymorphism was not linked with a higher genetic risk for T1D, the presence of a CT genotype was associated with a younger age of onset, poor control of HbA1c level and positive anti-GAD or IA-2 serum autoantibodies in Iranian Azeri population.
Copyright © 2015 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Age of onset; CTLA-4; GADA; Gene polymorphism; IA-2A; Type 1 diabetes

Mesh:

Substances:

Year:  2015        PMID: 26051683     DOI: 10.1016/j.imlet.2015.05.021

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  1 in total

1.  Association of CLTA-4 Gene Polymorphisms with Diabetes Mellitus: A Study Based on the Han Population of Northern China.

Authors:  Dongyue Ren; Lin He; Xiaoling Pang
Journal:  Diabetes Metab Syndr Obes       Date:  2022-09-03       Impact factor: 3.249

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.